H H Seydewitz

University Children's Hospital Basel, Bâle, Basel-City, Switzerland

Are you H H Seydewitz?

Claim your profile

Publications (32)138.16 Total impact

  • Source
    A S Ramalho · S Beck · D Penque · T Gonska · H H Seydewitz · M Mall · M D Amaral
    Journal of Medical Genetics 08/2003; 40(7):e88. · 5.64 Impact Factor
  • H H Seydewitz · J Gram · H D Bruhn · I Witt
    Hamostaseologie 06/2002; 22(2):7-10. DOI:10.1267/Hamo02020051 · 1.59 Impact Factor
  • M Mall · A Wissner · H H Seydewitz · J Kuehr · M Brandis · R Greger · K Kunzelmann
    [Show abstract] [Hide abstract]
    ABSTRACT: Rectal biopsies from cystic fibrosis (CF) patients show defective cAMP-activated Cl(-) secretion and an inverse response of the short-circuit current (I(sc)) toward stimulation with carbachol (CCh). Alternative Cl(-) channels are found in airway epithelia and have been attributed to residual Cl(-) secretion in CF colon. The aim of the present study was to investigate ion conductances causing reversed I(sc) upon cholinergic stimulation. Furthermore, the putative role of an alternative Ca(2+)-dependent Cl(-) conductance in human distal colon was examined. Cholinergic ion secretion was assessed in the absence and presence of cAMP-dependent stimulation. Transepithelial voltage and I(sc) were measured in rectal biopsies from non-CF and CF individuals by means of a perfused micro-Ussing chamber. Under baseline conditions, CCh induced a positive I(sc) in CF rectal biopsies but caused a negative I(sc) in non-CF subjects. The CCh-induced negative I(sc) in non-CF biopsies was gradually reversed to a positive response by incubating the biopsies in indomethacin. The positive I(sc) was significantly enhanced in CF and was caused by activation of a luminal K(+) conductance, as shown by the use of the K(+) channel blockers Ba(2+) and tetraethylammonium. Moreover, a cAMP-dependent luminal K(+) conductance was detected in CF individuals. We conclude that the cystic fibrosis transmembrane conductance regulator is the predominant Cl(-) channel in human distal colon. Unlike human airways, no evidence was found for an alternative Cl(-) conductance in native tissues from CF patients. Furthermore, we demonstrated that both Ca(2+)- and cAMP-dependent K(+) secretion are present in human distal colon, which are unmasked in rectal biopsies from CF patients.
    AJP Gastrointestinal and Liver Physiology 05/2000; 278(4):G617-24. · 3.74 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We report a large genomic deletion of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, viz., a deletion that is frequently observed in Central and Eastern Europe. The mutation, termed CFTRdele2,3(21 kb), deletes 21,080 bp spanning introns 1-3 of the CFTR gene. Transcript analyses have revealed that this deletion results in the loss of exons 2 and 3 in epithelial CFTR mRNA, thereby producing a premature termination signal within exon 4. In order to develop a simple polymerase chain reaction assay for this allele, we defined the end-points of the deletion at the DNA sequence level. We next screened for this mutation in a representative set of European and European-derived populations. Some 197 CF patients, including seven homozygotes, bearing this mutation have been identified during the course of our study. Clinical evaluation of CFTRdele2,3(21 kb) homozygotes and a comparison of compound heterozygotes for &#40F508/CFTRdele2,3(21 kb) with pairwise-matched &#40F508 homozygotes indicate that this deletion represents a severe mutation associated with pancreatic insufficiency and early age at diagnosis. Current data show that the mutation is particularly common in Czech (6.4% of all CF chromosomes), Russian (5.2%), Belorussian (3.3%), Austrian (2.6%), German (1.5%), Polish (1.5%), Slovenian (1.5%), Ukrainian (1.2%), and Slovak patients (1.1%). It has also been found in Lithuania, Latvia, Macedonia and Greece and has sporadically been observed in Canada, USA, France, Spain, Turkey, and UK, but not in CF patients from Bulgaria, Croatia, Romania or Serbia. Haplotype analysis has identified the same extragenic CF-haplotype XV-2c/KM.19 "A" and the same infrequent intragenic microsatellite haplotype 16-33-13 (IVS8CA-IVS17bTA-IVS17bCA) in all examined CFTRdele2,3(21 kb) chromosomes, suggesting a common origin for this deletion. We conclude that the 21-kb deletion is a frequent and severe CF mutation in populations of Eastern- and Western-Slavic descent.
    Human Genetics 02/2000; 106(3):259-268. DOI:10.1007/s004390000246 · 4.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: It is suggested that urinary eosinophil protein X (EPX) is a noninvasive tool to monitor bronchial inflammation in asthmatic children. However, circadian variation of the number and activation of eosinophils might possibly influence urinary EPX excretion. Measurements of urinary EPX (radioimmunoassay) were used to investigate circadian variation of eosinophilic activation and to monitor bronchial inflammation in children with asthma before and after treatment with corticosteroids. Urinary EPX excretion (microg/mmol creatinine) was measured in the morning and afternoon in 22 stable asthmatics and in 16 nonatopic, nonasthmatic controls to investigate circadian variation. Additionally, EPX excretion in the afternoon was analysed in 21 children with chronic asthma before and after 6 weeks of treatment with inhaled corticosteroids, and in seven children within 24 h of admission due to an asthma exacerbation and again 3 months after discharge. EPX excretion in the first morning urine sample of the day compared with the afternoon urine sample was significantly higher both in children with asthma (n = 22; mean +/- standard deviation: 179.7 +/- 97.3 vs 60.9 +/- 40.7 microg/mmol creatinine, P = 0.0001) and in nonatopic nonasthmatic controls (n = 16; 114.5 +/- 57.1 vs 53.4 +/- 29.0 microg/mmol creatinine, P = 0.0001). EPX excretion decreased significantly after 6 weeks of anti-inflammatory treatment in the group of children with chronic asthma (n = 21; 124.7 +/- 84.6 vs 87. 5 +/- 61.9 microg/mmol creatinine, P = 0.02) and in the group of children with an acute asthma exacerbation 3 months after discharge (n = 7; 233.2 +/- 174.5 vs 75.8 +/- 59.5 microg/mmol creatinine, P = 0.02). This study suggests a circadian variation of EPX excretion in children with asthma and in nonatopic, nonasthmatic controls. Measurement of EPX excretion is helpful monitoring therapy in asthmatic children if circadian variation is considered.
    Clinical & Experimental Allergy 12/1999; 29(11):1497-501. DOI:10.1046/j.1365-2222.1999.00731.x · 4.32 Impact Factor
  • Source
    M V Kopp · C Ulmer · G Ihorst · H H Seydewitz · T Frischer · J Forster · J Kuehr
    [Show abstract] [Hide abstract]
    ABSTRACT: In order to investigate nasal inflammation and subsequent adaptation after ambient ozone exposure, nasal lavage (NL) fluid was collected from 170 schoolchildren on 11 occasions (time points) between March and October. Eosinophil cationic protein (ECP), albumin and leukocytes were quantified as markers of nasal inflammation. The highest half-hour outdoor O3 concentration for each individual on the day prior to the NL was used as a measure of exposure (O3indiv). To avoid confounding with exposure to common environmental allergens, the study population was restricted to children without sensitization to inhalant allergens. In the initial period of increased O3 levels in May (time point 4), with a median O3indiv of 135 microg x m(-3) (5th-95th percentile 100-184 microg x m(-3)), the highest medians of all 11 leukocyte and ECP measurements were observed. The highest O3indiv were observed in June at time point 7 (O3indiv 173 microg x m(-3), 5th-95th percentile 120-203 microg x m(-3)). Cross-sectional analysis of all 11 time points revealed no significant association of O3indiv on the one hand and ECP, albumin and leukocyte levels on the other. A multivariable model estimated using generalized estimating equations showed a statistically significant association of O3indiv and leukocytes and ECP as the dependent variable, when time points 1-4 were analysed (p<0.05). In the same model, this association diminished continuously when time points 5-11 were added stepwise, in spite of high O3 exposure. Not even a tendency towards an O3 effect could be recognized when time points 1-8 were considered. The results indicate: 1) acute inflammation of the nasal mucosa after the first increase in ambient ozone levels, with 2) a significant dose-dependent increase in leukocyte and eosinophil cationic protein levels, and 3) possible adaptation of the nasal mucosa in spite of constant high levels of ozone exposure in children during the summer season.
    European Respiratory Journal 10/1999; 14(4):854-61. · 7.13 Impact Factor
  • Source
    M.V. Kopp · C. Ulmer · G. Ihorst · H.H. Seydewitz · T. Frischer · J. Forster · J. Kuehr
    [Show abstract] [Hide abstract]
    ABSTRACT: In order to investigate nasal inflammation and subsequent adaptation after ambient ozone exposure, nasal lavage (NL) fluid was collected from 170 schoolchildren on 11 occasions (time points) between March and October.Eosinophil cationic protein (ECP), albumin and leukocytes were quantified as markers of nasal inflammation. The highest half-hour outdoor O3 concentration for each individual on the day prior to the NL was used as a measure of exposure (O3indiv). To avoid confounding with exposure to common environmental allergens, the study population was restricted to children without sensitization to inhalant allergens.In the initial period of increased O3 levels in May (time point 4), with a median O3indiv of 135 µg·m-3 (5th –95th percentile 100–184 µg·m-3), the highest medians of all 11 leukocyte and ECP measurements were observed. The highest O3indiv were observed in June at time point 7 (O3indiv 173 µg·m-3, 5th–95th percentile 120–203 µg·m-3). Cross-sectional analysis of all 11 time points revealed no significant association of O3indiv on the one hand and ECP, albumin and leukocyte levels on the other. A multivariable model estimated using generalized estimating equations showed a statistically significant association of O3indiv and leukocytes and ECP as the dependent variable, when time points 1–4 were analysed (p<0.05). In the same model, this association diminished continuously when time points 5–11 were added stepwise, in spite of high O3 exposure. Not even a tendency towards an O3 effect could be recognized when time points 1–8 were considered.The results indicate: 1) acute inflammation of the nasal mucosa after the first increase in ambient ozone levels, with 2) a significant dose-dependent increase in leukocyte and eosinophil cationic protein levels, and 3) possible adaptation of the nasal mucosa in spite of constant high levels of ozone exposure in children during the summer season.
    European Respiratory Journal 09/1999; 14(4):854 - 861. DOI:10.1034/j.1399-3003.1999.14d22.x · 7.13 Impact Factor
  • S Beck · J Kühr · V V Schütz · H H Seydewitz · M Brandis · R Greger · K Kunzelmann
    [Show abstract] [Hide abstract]
    ABSTRACT: Cystic fibrosis (CF) is characterized by defective Cl− and enhanced Na+ conductance, both due to malfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) protein in airway epithelial cells. In the present study we examined whether expression of CFTR mRNA (CFTR messenger ribonucleic acid) is different in airway epithelia derived from either CF patients or healthy volunteers. Moreover, we tried to correlate differences in epithelial Cl− and Na+ conductance with the level of CFTR mRNA expression and studied whether these properties correlate to the clinical phenotype of CF patients. To that end, CFTR mRNA was determined by means of quantitative reverse transcriptase polymerase chain reaction (RT-PCR) and cyclic adenosine monophosphate (cAMP)-activated Cl− and epithelial Na+ conductances were examined in airway epithelial cells using microelectrode techniques. Complementary in vitro data were obtained from cultured CF and non-CF airway epithelial cell lines. Genotype and Shwachman score were assessed for each patient. We found variable levels of CFTR mRNA expression in airway cells of both CF patients and healthy volunteers. As expected, epithelial Na+ conductance was enhanced and CFTR Cl− conductance was absent in airway cells from CF patients. However, CFTR mRNA expression did not correlate with either electrophysiological properties or Shwachman scores obtained from CF patients. In addition, CFTR mRNA expression did not correlate to Cl− conductance in cultured CF and non-CF airway epithelial cells. These results indicate a lack of correlation between levels of CFTR mRNA and CFTR function, and that only small amounts of CFTR are required for expression of the CFTR Cl− conductance. Pediatr Pulmonol. 1999; 27:251–259.
    Pediatric Pulmonology 05/1999; 27(4):251-9. DOI:10.1002/(SICI)1099-0496(199904)27:43.0.CO;2-B · 2.30 Impact Factor
  • M Mall · M Bleich · M Schürlein · J Kühr · H H Seydewitz · M Brandis · R Greger · K Kunzelmann
    [Show abstract] [Hide abstract]
    ABSTRACT: Cl- secretion in the colon can be activated by an increase of either intracellular Ca2+ or cAMP. In this study we examined a possible interdependence of the two second-messenger pathways in human colonic epithelium. When measured in a modified Ussing chamber, carbachol (CCH; 100 micromol/l, basolateral), via an increase in cytosolic Ca2+ concentration ([Ca2+]i), activated a transient lumen-negative equivalent short-circuit current (Isc) [change (Delta) in Isc = -79.4 +/- 7.5 microA/cm2]. Previous studies indicated that intracellular Ca2+ directly acts on basolateral K+ channels, thus enhancing driving force for luminal Cl- exit. Increased intracellular cAMP (by basolateral addition of 100 micromol/l IBMX and 1 micromol/l forskolin) activated a sustained lumen-negative current (DeltaIsc = -42.4 +/- 7.2 microA/cm2) that was inhibited by basolateral trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2, 2-dimethyl&2-chromane (10 micromol/l), a blocker of KvLQT1 channels. In the presence of elevated cAMP, the CCH-activated currents were augmented (DeltaIsc = 167.7 +/- 32.7 microA/cm2), suggesting cooperativity of the Ca2+- and cAMP-mediated responses. Inhibition of endogenous cAMP production by indomethacin (10 micromol/l) significantly reduced CCH-activated currents and even reversed the polarity in 70% of the experiments. The transient lumen-positive Isc was probably due to activation of apical K+ channels because it was blocked by luminal Ba2+ (5 mmol/l) and tetraethylammonium (10 mmol/l). In the presence of indomethacin (10 micromol/l, basolateral), an increase of cAMP activated a sustained negative Isc. Under these conditions, CCH induced a large further increase in lumen-negative Isc (DeltaIsc = -100.0 +/- 21.0 microA/cm2). We conclude that CCH acting via [Ca2+]i can induce Cl- secretion only in the presence of cAMP, i.e., when luminal Cl- channels are already activated. The activation of a luminal and basolateral K+ conductance by CCH may be essential for transepithelial KCl secretion in human colon.
    The American journal of physiology 01/1999; 275(6 Pt 1):G1274-81. · 3.28 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Congenital absence of the vas deferens (CAVD) is a frequent cause for obstructive azoospermia and accounts for 1%-2% of male infertility. A high incidence of mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene has recently been reported in males with CAVD. We have investigated a cohort of 106 German patients with congenital bilateral or unilateral absence of the vas deferens for mutations in the coding region, flanking intron regions and promotor sequences of the CFTR gene. Of the CAVD patients, 75% carried CFTR mutations or disease-associated CFTR variants, such as the "5T" allele, on both chromosomes. The distribution of mutation genotypes clearly differed from that observed in cystic fibrosis. None of the CAVD patients was homozygous for delta F508 and none was compound heterozygous for delta F508 and a nonsense or frameshift mutation. Instead, homozygosity was found for a few mild missense or splicing mutations, and the majority of CAVD mutations were missense substitutions. Twenty-one German CAVD patients were compound heterozygous for delta F508 and R117H, which was the most frequent CAVD genotype in our study group. Haplotype analysis indicated a common origin for R117H in our population, whereas another frequent CAVD mutation, viz. the "5T allele" was a recurrent mutation on different intragenic haplotypes and multiple ethnic backgrounds. We identified a total of 46 different mutations and variants, of which 15 mutations have not previously been reported. Thirteen novel missense mutations and one unique amino-acid insertion may be confined to the CAVD phenotype. A few splice or missense variants, such as F508C or 1716 G-->A, are proposed here as possible candidate CAVD mutations with an apparently reduced penetrance. Clinical examination of patients with CFTR mutations on both chromosomes revealed elevated sweat chloride concentrations and discrete symptoms of respiratory disease in a subset of patients. Thus, our collaborative study shows that CAVD without renal malformation is a primary genital form of cystic fibrosis in the vast majority of German patients and links the particular expression of clinical symptoms in CAVD with a distinct subset of CFTR mutation genotypes.
    Human Genetics 09/1997; 100(3-4):365-77. · 4.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Das hyperammonämische Koma ist eine akut lebensbedrohliche Stoffwechselentgleisung. Die häufigsten kongenitalen Ursachen sind Enzymdefekte im Harnstoffzyklus und im Abbau von organischen Säuren. Die Frühdiagnose und eine sofortige aggressive Therapie sind die entscheidenden Voraussetzungen zur Vermeidung irreversibler Hirnschäden und letaler Verläufe. Das Therapieziel ist eine rasche Senkung des Ammoniaks und anderer neurotoxischer Metaboliten. Die therapeutischen Grundprinzipien beinhalten 1. eine restriktive Proteinzufuhr unter dem Erhalt essentieller Aminosäuren, 2. die Unterbrechung des Proteinkatabolismus mittels hochkalorischer Ernährung, 3. eine medikamentöse Aktivierung alternativer Wege der Stickstoffausscheidung sowie 4. apparative Blutreinigungsverfahren. Das optimale Dialyseverfahren ist umstritten. Wir haben 4 Neugeborene und Säuglinge in einem hyperammonämischen Koma im Rahmen von Stoffwechselerkrankungen mittels Hämodialyse oder Hämofiltration behandelt. Die Kasuistiken bestätigen die Effektivität und Komplikationsarmut beider Verfahren. Diskussion: In der Behandlung von lebensbedrohlichen Hyperammonämien bei Neugeborenen und Säuglingen sind Hämodialysen und Hämofiltrationen die Behandlungsmethoden der Wahl. Die invasive Blutreinigung ist mit einer konsequenten diätetischen und medikamentösen Therapie zu optimieren. Der prognostische Nutzen einer effizienten Blutreinigung bei ausgeprägter Hyperammonämie rechtfertigt einen unverzüglichen Transport in das nächstgelegene pädiatrische Dialysezentrum. Inborn errors of the urea cycle and of the organic acid metabolism can cause acute hyperammonemia in neonates which, if untreated, leads to coma, severe brain damage or death. These complications, however, can be prevented by proper diagnosis and early therapeutic intervention. Rapid decline in ammonia blood levels are essential and can be achieved by the following four therapeutic principles 1. restriction of protein intake (while maintaining essential amino acids), 2. reduction of protein catabolism by a hypercaloric diet, 3. activation of alternative pathways of ammonia elimination, and 4. elimination of ammonia from the circulation by dialysis. We report on 4 cases who were submitted because of acute hyperammonemic coma. All patients were treated immediately after diagnosis with hemodialysis (HD) or hemofiltration (HF). In all 4 patients blood ammonia levels were rapidly decreased to normal values leading to significant improvements of the neurologic state. The long term outcomes were, however, determined by the underlying metabolic disorder. Discussion: Our case reports confirm the effectiveness of HD and HF in the treatment of acute hyperammonemic coma. Since the diagnosis and the prognosis of metabolic disorders are rarely known at the time when the patient becomes symptomatic and needs therapy, any neonate with acute hyperammonemia should be referred to a special care unit where technical facilities for extracorporal dialysis are available.
    Monatsschrift Kinderheilkunde 01/1997; 145(7):714-718. DOI:10.1007/s001120050173 · 0.28 Impact Factor
  • D Matern · H Seydewitz · H Niederhoff · H Wiebusch · M Brandis
    [Show abstract] [Hide abstract]
    ABSTRACT: An 8-year-old boy with frequently recurring pancreatitis-like abdominal pain, Fredrickson type V dyslipidaemia, and significantly decreased post-heparin plasma lipoprotein lipase (LPL) activity is described. In order to exclude familial LPL deficiency, the complete LPL coding gene sequence was analysed revealing compound heterozygosity for two mutations (Asp9Asn, Ser447Ter) which are not supposed to considerably impair lipolytic enzyme activity. However, until now the combination of both these mutations in one patient has not been observed. In addition to the common symptoms of LPL deficiency, a striking feature of unknown origin was hypersalivation. Treatment including a fat-restricted diet, omega-3 fatty acids, and nicotinic acid led to long symptoms-free intervals. Symptoms recurred however when the diet was not strictly adhered to. CONCLUSION: LPL deficiency is a rare cause of abdominal pain in childhood and deserves careful treatment in order to avoid pancreatitis. The presented patients is a unique compound heterozygote for two mutations which do not abolish lipolytic activity in the homozygote state. Identification of other individuals with this genotype is necessary to understand the phenotype in our patient.
    European Journal of Pediatrics 09/1996; 155(8):660-4. DOI:10.1007/s004310050463 · 1.98 Impact Factor
  • M. Chen · H. Seydewitz · B. Winckelmann · M. Nauck · H. Wieland · L. Witt · W. März
    Atherosclerosis 06/1995; 115. DOI:10.1016/0021-9150(95)96391-5 · 3.97 Impact Factor
  • W März · H Seydewitz · B Winkelmann · M Chen · M Nauck · I Witt
    The Lancet 03/1995; 345(8948):526. DOI:10.1016/S0140-6736(95)90626-6 · 45.22 Impact Factor
  • H. H. Seydewitz · H. Müller · I. Witt
    Human Mutation 01/1995; 6(3):278-278. DOI:10.1002/humu.1380060319 · 5.05 Impact Factor
  • I Witt · S Beck · H H Seydewitz · C Tasangil · W Schenck
    [Show abstract] [Hide abstract]
    ABSTRACT: A novel homozygous GTG-->GCG (Val 325-->Ala) substitution was detected in the protein C gene of a newborn causing severe purpura fulminans post partum. In the consanguineous parents and two further infants a heterozygous type 1 protein C deficiency was found. Up to now the heterozygous individuals are clinically unaffected. The mutation co-segregates with the protein C deficiency state. It creates a restriction enzyme (Sac II) cleavage site.
    Blood Coagulation and Fibrinolysis 09/1994; 5(4):651-3. · 1.38 Impact Factor
  • H H Seydewitz · J Gram · H D Bruhn · I Witt
    [Show abstract] [Hide abstract]
    ABSTRACT: A congenital fibrinogen variant in a German family is described which has been identified as a substitution of His in position 16 of the A alpha-chain for Arg, manifested over three generations in heterozygous form. The characterization is based on the reaction of the variant fibrinogen with thrombin and reptilase, on the HPLC-chromatographic properties and the amino acid composition of the abnormal fibrinopeptide A. Clinical observations in the affected family members (neither haemorrhagic nor thrombophilic tendencies), the results of routine coagulation tests (normal global clotting tests, prolonged thrombin and thrombin-coagulase time, decreased fibrinogen concentration in functional as opposed to immunological tests), and the autosomal co-dominant modus of inheritance of the fibrinogen variant are all in complete agreement with other reports in the literature concerning the same amino acid exchange. The results of our experiments with fibrinogen Kiel allow no definite conclusion regarding the question of whether it consists of pure homodimers or as of a mixture of homo- and heterodimers.
    Blood Coagulation and Fibrinolysis 09/1991; 2(4):501-6. · 1.38 Impact Factor
  • H. H. Seydewitz · J. Gram · H. D. Bruhn · I. Witt
    [Show abstract] [Hide abstract]
    ABSTRACT: A congenital fibrinogen variant in a German family is described which has been identified as a substitution of His in position 16 of the A-alpha-chain for Arg, manifested over three generations in heterozygous form. The characterization is based on the reaction of the variant fibrinogen with thrombin and reptilase, on the HPLC-chromatographic properties and the amino acid composition of the abnormal fibrinopeptide A. Clinical observations in the affected family members (neither haemorrhagic nor thrombophilic tendencies), the results of routine coagulation tests (normal global clotting tests, prolonged thrombin and thrombin-coagulase time, decreased fibrinogen concentration in functional as opposed to immunological tests), and the autosomal co-dominant modus of inheritance of the fibrinogen variant are all in complete agreement with other reports in the literature concerning the same amino acid exchange. The results of our experiments with fibrinogen Kiel allow no definite conclusion regarding the question of whether it consists of pure homodimers or as of a mixture of homo- and heterodimers.
    Blood Coagulation and Fibrinolysis 08/1991; 2(4):501-506. DOI:10.1097/00001721-199108000-00002 · 1.38 Impact Factor
  • H H Seydewitz · I Witt
    Thrombosis Research 10/1989; 55(6):785-90. DOI:10.1016/0049-3848(89)90309-5 · 2.43 Impact Factor
  • I WITT · H.-H. Seydewitz
    Fibrinolysis 12/1988; 2. DOI:10.1016/0268-9499(88)90669-8

Publication Stats

640 Citations
138.16 Total Impact Points

Institutions

  • 1999
    • University Children's Hospital Basel
      Bâle, Basel-City, Switzerland
  • 1984–1999
    • University of Freiburg
      • • Department of Pediatrics
      • • Institute of Biology I
      Freiburg, Baden-Württemberg, Germany
  • 1991
    • Christian-Albrechts-Universität zu Kiel
      Kiel, Schleswig-Holstein, Germany
  • 1981
    • Evangelische Hochschule Freiburg, Germany
      Freiburg, Baden-Württemberg, Germany